A protein array screen for Kaposi's sarcoma-associated herpesvirus lana interactors links LANA to TIP60, PP2A activity, and telomere shortening

Journal of Virology

Volumn 86, Issue 9, 2012, Pages 5179-5191

  Shamay, Meir ^a   Liu, Jianyong ^a   Li, Renfeng ^a   Liao, Gangling ^a   Shen, Li ^a   Greenway, Melanie ^a   Hu, Shaohui ^a   Zhu, Jian ^a   Xie, Zhi ^a   Ambinder, Richard F ^a   Qian, Jiang ^a   Zhu, Heng ^a   Hayward, S Diane ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CELL PROTEIN; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN E6; PROTEIN LANA; PYGOPUS HOMOLG 2; REPLICATION PROTEIN A1; REPLICATION PROTEIN A2; TAT INTERACTIVE PROTEIN 60; TELOMERIC REPEAT BINDING FACTOR 1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

ADENOVIRUS; ARTICLE; CELL IMMORTALIZATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEOMICS; SIMIAN VIRUS 40; TELOMERE SHORTENING; VIRUS CELL INTERACTION;

ANTIGENS, VIRAL; CELL LINE; GENE EXPRESSION; HISTONE ACETYLTRANSFERASES; HMGA PROTEINS; HMGB1 PROTEIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING; PROTEIN PHOSPHATASE 2; REPLICATION PROTEIN A; TELOMERE; TELOMERE SHORTENING; TELOMERIC REPEAT BINDING PROTEIN 1; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

ADENOVIRIDAE; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS; LANA; PYGOPUS; SIMIAN VIRUS 40;

EID: 84861321790     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00169-12     Document Type: Article

References (119)

1. An J, Sun Y, Rettig MB. 2004. Transcriptional coactivation of c-Jun by the KSHV-encoded LANA. Blood 103:222-228.
2. Anantha RW, Borowiec JA. 2009. Mitotic crisis: the unmasking of a novel role for RPA. Cell Cycle 8:357-361.
3. Arnold HK, Sears RC. 2008. A tumor suppressor role for PP2AB56alpha through negative regulation of c-Myc and other key oncoproteins. Cancer Metastasis Rev. 27:147-158.
4. Atanasiu C, Deng Z, Wiedmer A, Norseen J, Lieberman PM. 2006. ORC binding to TRF2 stimulates OriP replication. EMBO Rep. 7:716-721.
5. Awasthi S, et al. 2005. A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions. Mol. Cell. Biol. 25:6178-6198.
6. Barbera AJ, et al. 2006. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311:856-861.
7. Blasco MA, et al. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34.
8. Bubman D, Guasparri I, Cesarman E. 2007. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latencyassociated nuclear antigen. Oncogene 26:4979-4986.
9. Cai Q, et al. 2006. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: latency control under low oxygen conditions. J. Virol. 80:7965-7975.
10. Cesare AJ, Reddel RR. 2010. Alternative lengthening of telomeres: models, mechanisms and implications. Nat. Rev. Genet. 11:319-330.
11. Cesarman E. 2011. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett. 305:163-174.
12. Charvet C, et al. 2011. Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Mol. Cell 42:584-596.
13. Chen C, Umezu K, Kolodner RD. 1998. Chromosomal rearrangements occur in S. cerevisiae rfa1 mutator mutants due to mutagenic lesions processed by double-strand-break repair. Mol. Cell 2:9-22.
14. Chen J, et al. 2010. Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion. Mol. Cell. Biol. 30:5621-5635.
15. Chen W, Dittmer DP. 2011. Ribosomal protein S6 interacts with the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 85:9495-9505.
16. Chen W, Hilton IB, Staudt MR, Burd CE, Dittmer DP. 2010. Distinct p53, p53:LANA, and LANA complexes in Kaposi's sarcoma-associated herpesvirus lymphomas. J. Virol. 84:3898-3908.
17. Chen Y, et al. 2007. Structural and biochemical insights into the regulation of protein phosphatase 2A by small T antigen of SV40. Nat. Struct. Mol. Biol. 14:527-534.
18. Cheng J, DeCaprio JA, Fluck MM, Schaffhausen BS. 2009. Cellular transformation by simian virus 40 and murine polyoma virus T antigens. Semin. Cancer Biol. 19:218-228.
19. Cho US, et al. 2007. Structural basis of PP2A inhibition by small T antigen. PLoS Biol. 5:e202.
20. Chou S. 2009. Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir. Antimicrob. Agents Chemother. 53:81-85.
21. Col E, et al. 2005. HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. EMBO J. 24:2634-2645.
22. Creaven M, et al. 1999. Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. Biochemistry 38: 8826-8830.
23. d'Adda di Fagagna F, et al. 2003. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194-198.
24. De Leon Vazquez E, Kaye KM. 2011. The internal Kaposi's sarcomaassociated herpesvirus LANA regions exert a critical role on episome persistence. J. Virol. 85:7622-7633.
25. Deng Z, Atanasiu C, Burg JS, Broccoli D, Lieberman PM. 2003. Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J. Virol. 77:11992-12001.
26. Fairman MP, Stillman B. 1988. Cellular factors required for multiple stages of SV40 DNA replication in vitro. EMBO J. 7:1211-1218.
27. Fakhari FD, Jeong JH, Kanan Y, Dittmer DP. 2006. The latencyassociated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma. J. Clin. Invest. 116:735-742.
28. Fazzio TG, Huff JT, Panning B. 2008. An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 134:162-174.
29. Flore O, et al. 1998. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394:588-592.
30. Friborg J, Jr, Kong W, Hottiger MO, Nabel GJ. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889-894.
31. Fujimuro M, Hayward SD. 2003. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J. Virol. 77:8019-8030.
32. Fujimuro M, Liu J, Zhu J, Yokosawa H, Hayward SD. 2005. Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J. Virol. 79:10429-10441.
33. Fujimuro M, et al. 2003. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9:300-306.
34. Fukushi M, et al. 2003. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha. Virus Genes 27:237-247.
35. Ganem D. 2007. KSHV-induced oncogenesis. In Arvin A, et al (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
36. Gantt S, Casper C. 2011. Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr. Opin. Infect. Dis. 24:295-301.
37. Grundhoff A, Ganem D. 2003. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J. Virol. 77:2779-2783.
38. Hackett JA, Feldser DM, Greider CW. 2001. Telomere dysfunction increases mutation rate and genomic instability. Cell 106:275-286.
39. Han SJ, Hu J, Pierce B, Weng Z, Renne R. 2010. Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins. J. Gen. Virol. 91:2203-2215.
40. Han Y, Loo YM, Militello KT, Melendy T. 1999. Interactions of the papovavirus DNA replication initiator proteins, bovine papillomavirus type 1 E1 and simian virus 40 large T antigen, with human replication protein A. J. Virol. 73:4899-4907.
41. Harrison SM, Whitehouse A. 2008. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter. FEBS Lett. 582:3080-3084.
42. Hillion J, et al. 2009. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer. Mol. Cancer Res. 7:1803-1812.
43. Hu J, Garber AC, Renne R. 2002. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76:11677-11687
44. Hu J, Liu E, Renne R. 2009. Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus. J. Virol. 83:11051-11063.
45. Hu J, Renne R. 2005. Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J. Virol. 79:2637-2642.
46. Hu S, et al. 2009. Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139:610-622.
47. Jha S, et al. 2010. Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway. Mol. Cell 38:700-711.
48. Kaul R, Verma SC, Robertson ES. 2007. Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. Virology 364:317-329.
49. Kelley-Clarke B, De Leon-Vazquez E, Slain K, Barbera AJ, Kaye KM. 2009. Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence. J. Virol. 83:4326-4337.
50. Kimura M, et al. 2010. Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths. Nat. Protoc. 5:1596-1607.
51. Kobayashi Y, et al. 2010. Expression of mutant RPA in human cancer cells causes telomere shortening. Biosci. Biotechnol. Biochem. 74:382-385.
52. Krithivas A, Fujimuro M, Weidner M, Young DB, Hayward SD. 2002. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76:11596-11604.
53. Krithivas A, Young DB, Liao G, Greene D, Hayward SD. 2000. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J. Virol. 74:9637-9645.
54. Kusano S, Eizuru Y. 2010. Human I-mfa domain proteins specifically interact with KSHV LANA and affect its regulation of Wnt signalingdependent transcription. Biochem. Biophys. Res. Commun. 396:608-613.
55. Lan K, Kuppers DA, Robertson ES. 2005. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway. J. Virol. 79:3468-3478.
56. Lan K, Kuppers DA, Verma SC, Robertson ES. 2004. Kaposi's sarcomaassociated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virusmediated control of latency. J. Virol. 78:6585-6594.
57. Li L, Lu X, Peterson CA, Legerski RJ. 1995. An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair. Mol. Cell. Biol. 15:5396-5402.
58. Li Q, Zhou F, Ye F, Gao SJ. 2008. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology 379:234-244.
59. Li R, et al. 2011. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe 10:390-400.
60. Lim C, Gwack Y, Hwang S, Kim S, Choe J. 2001. The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcomaassociated herpesvirus. J. Biol. Chem. 276:31016-31022.
61. Liu J, Martin HJ, Liao G, Hayward SD. 2007. The Kaposi's sarcomaassociated herpesvirus LANA protein stabilizes and activates c-Myc. J. Virol. 81:10451-10459.
62. Lu F, Day L, Gao SJ, Lieberman PM. 2006. Acetylation of the latencyassociated nuclear antigen regulates repression of Kaposi's sarcomaassociated herpesvirus lytic transcription. J. Virol. 80:5273-5282.
63. Mallory JC, et al. 2003. Amino acid changes in Xrs2p, Dun1p, and Rfa2p that remove the preferred targets of theATMfamily of protein kinases do not affect DNA repair or telomere length in Saccharomyces cerevisiae. DNA Rep. (Amst.) 2:1041-1064.
64. Marini F, et al. 2006. DNA nucleotide excision repair-dependent signaling to checkpoint activation. Proc. Natl. Acad. Sci. U. S. A. 103:17325-17330.
65. Matsumura S, Persson LM, Wong L, Wilson AC. 2010. The latencyassociated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains. J. Virol. 84:2318-2330.
66. Missura M, et al. 2001. Double-check probing of DNA bending and unwinding by XPA-RPA: an architectural function in DNA repair. EMBO J. 20:3554-3564.
67. Miura N, et al. 1997. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet. Cytogenet. 93:56-62.
68. Mullaney BP, Ng VL, Herndier BG, McGrath MS, Pallavicini MG. 2000. Comparative genomic analyses of primary effusion lymphoma. Arch. Pathol. Lab. Med. 124:824-826.
69. Muromoto R, et al. 2006. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA. FEBS Lett. 580:93-98.
70. Nair P, Pan H, Stallings RL, Gao SJ. 2006. Recurrent genomic imbalances in primary effusion lymphomas. Cancer Genet. Cytogenet. 171: 119-121.
71. Norrback KF, Roos G. 1997. Telomeres and telomerase in normal and malignant haematopoietic cells. Eur. J. Cancer 33:774-780.
72. O'Callaghan N, Dhillon V, Thomas P, Fenech M. 2008. A quantitative real-time PCR method for absolute telomere length. Biotechniques 44: 807-809.
73. Ohsaki E, et al. 2004. Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J. Virol. 78:9936-9946.
74. Ottinger M, et al. 2006. Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest. J. Virol. 80: 10772-10786.
75. Pan H, Zhou F, Gao SJ. 2004. Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. Cancer Res. 64:4064-4068.
76. Park CJ, Lee JH, Choi BS. 2005. Solution structure of the DNA-binding domain of RPA from Saccharomyces cerevisiae and its interaction with single-stranded DNA and SV40 T antigen. Nucleic Acids Res. 33:4172-4181.
77. Patel JH, et al. 2004. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol. Cell. Biol. 24:10826-10834.
78. Paudel N, Sadagopan S, Balasubramanian S, Chandran B. 2012. Kaposi's sarcoma associated herpesvirus (KSHV) latency associated nuclear antigen (LANA-1) and angiogenin interact with common host proteins including annexin A2 that is essential for the survival of latently infected cells. J. Virol. 86:1589-1607.
79. Platt GM, Simpson GR, Mittnacht S, Schulz TF. 1999. Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J. Virol. 73:9789-9795.
80. Radkov SA, Kellam P, Boshoff C. 2000. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6:1121-1127.
81. Reichenbach P, et al. 2003. A human homolog of yeast Est1 associates with telomerase and uncaps chromosome ends when overexpressed. Curr. Biol. 13:568-574.
82. Reitsma JM, et al. 2011. Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest. Cell Host Microbe 9:103-114.
83. Remes K, et al. 2000. Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br. J. Cancer 82:601-607.
84. Resar LM. 2010. The high mobility group A1 gene: transforming inflammatory signals into cancer? Cancer Res. 70:436-439.
85. Rossetto C, Yamboliev I, Pari GS. 2009. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis. J. Virol. 83:8492-8501.
86. Roupelieva M, et al. 2010. Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogenactivated protein kinase pathways via interactions with the Mediator complex. J. Gen. Virol. 91:1138-1149.
87. Ruediger R, Ruiz J, Walter G. 2011. Human cancer-associated mutations in the Aα subunit of protein phosphatase 2A increase lung cancerincidence in Aα knock-in and knockout mice. Mol. Cell. Biol. 31:3832-3844.
88. Sarek G, et al. 2007. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. J. Clin. Invest. 117:1019-1028.
89. Schramke V, et al. 2004. RPA regulates telomerase action by providing Est1p access to chromosome ends. Nat. Genet. 36:46-54.
90. Shamay M, Greenway M, Liao G, Ambinder RF, Hayward SD. 2010. De novo DNA methyltransferase DNMT3b interacts with NEDD8-modified proteins. J. Biol. Chem. 285:36377-36386.
91. Shamay M, Krithivas A, Zhang J, Hayward SD. 2006. Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcomaassociated herpesvirus LANA. Proc. Natl. Acad. Sci. U. S. A. 103:14554-14559.
92. Shi Y. 2009. Serine/threonine phosphatases: mechanism through structure. Cell 139:468-484.
93. Si H, Robertson ES. 2006. Kaposi's sarcoma-associated herpesvirusencoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function. J. Virol. 80:697-709.
94. Si H, Verma SC, Robertson ES. 2006. Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins. J. Virol. 80:9017-9030.
95. Smith J, Zou H, Rothstein R. 2000. Characterization of genetic interactions with RFA1: the role of RPA in DNA replication and telomere maintenance. Biochimie 82:71-78.
96. Song MJ, et al. 2004. The DNA architectural protein HMGB1 facilitates RTA-mediated viral gene expression in gamma-2 herpesviruses. J. Virol. 78:12940-12950.
97. Stedman W, Deng Z, Lu F, Lieberman PM. 2004. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J. Virol. 78:12566-12575.
98. Sun Y, Jiang X, Chen S, Fernandes N, Price BD. 2005. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. U. S. A. 102:13182-13187.
99. Sykes SM, et al. 2006. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 24:841-851.
100. Tang D, Kang R, Zeh HJ III, Lotze MT. 2010. High-mobility group box 1 and cancer. Biochim. Biophys. Acta 1799:131-140.
101. Tang J, Gordon GM, Muller MG, Dahiya M, Foreman KE. 2003. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells. J. Virol. 77:5975-5984.
102. Verdun RE, Karlseder J. 2007. Replication and protection of telomeres. Nature 447:924-931.
103. Verma SC, et al. 2006. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus. J. Virol. 80:11178-11190.
104. Verma SC, Borah S, Robertson ES. 2004. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J. Virol. 78:10348-10359.
105. Virshup DM, Shenolikar S. 2009. From promiscuity to precision: protein phosphatases get a makeover. Mol. Cell 33:537-545.
106. Wang Y, et al. 2005. Mutation in Rpa1 results in defective DNA doublestrand break repair, chromosomal instability and cancer in mice. Nat. Genet. 37:750-755.
107. Watanabe A, et al. 2007. A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences. Virus Genes 34:127-136.
108. Wold MS. 1997. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66:61-92.
109. Wold MS, Kelly T. 1988. Purification and characterization of replication protein A, a cellular protein required for in vitro replication of simian virus 40 DNA. Proc. Natl. Acad. Sci. U. S. A. 85:2523-2527.
110. Wong LY, Wilson AC. 2005. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA. J. Virol. 79:13829-13836.
111. Wood LJ, et al. 2000. HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol. Cell. Biol. 20:5490-5502.
112. Wu YH, et al. 2011. The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Blood 118:2896-2905.
113. Xiao H, Chung J, Kao HY, Yang YC. 2003. Tip60 is a co-repressor for STAT3. J. Biol. Chem. 278:11197-11204.
114. Yang J, et al. 1999. Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274:26141-26148.
115. Ye F, Lei X, Gao SJ. 2011. Mechanisms of Kaposi's sarcoma-associated herpesvirus latency and reactivation. Adv. Virol. 2011:pii=193860.
116. You J, et al. 2006. Kaposi's sarcoma-associated herpesvirus latencyassociated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J. Virol. 80:8909-8919.
117. Zhang A, et al. 2004. Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene 23:7441-7447.
118. Zhang D, Frappier L, Gibbs E, Hurwitz J, O'Donnell M. 1998. Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus. Nucleic Acids Res. 26:631-637.
119. Zhang Y, Rohde LH, Wu H. 2009. Involvement of nucleotide excision and mismatch repair mechanisms in double-strand break repair. Curr. Genomics 10:250-258.